Global Anthrax Vaccines Market Insights and Forecast to 2028

Q: Who are the key players in the anthrax vaccines market?

Some of the key players are Emergent Biosolutions, Merial , Merck, Zoetis Inc, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC, Zoetis, Zoetis, China, Russia, Segment, Companies, Companies, Market Participants, Companies, Companies, Key, Others.

Code: QYRE-Auto-8216

Report

January 2022

Pages:128

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Emergent Biosolutions

Indian Immunologicals

Botswana Vaccine Institute

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Market Analysis and Insights: Global Anthrax Vaccines Market

Due to the COVID-19 pandemic, the global Anthrax Vaccines market size is estimated to be worth US$ 709 million in 2022 and is forecast to a readjusted size of US$ 1100.3 million by 2028 with a CAGR of 7.6% during the review period.

Fully considering the economic change by this health crisis, Live Vaccines accounting for % of the Anthrax Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Human Use segment is altered to an % CAGR throughout this forecast period.

Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.

North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.

In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.

Global Anthrax Vaccines Scope and Segment

Anthrax Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anthrax Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Live Vaccines

Cell free PA Vaccines

Segment by Application

Human Use

Animal Use

BY COMPANY

Emergent BioSolutions

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biogénesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Santé Animale

Intervac

JOVAC

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

Emergent Biosolutions

Indian Immunologicals

Botswana Vaccine Institute

1 Study Coverage

1.1 Anthrax Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Live Vaccines

1.2.3 Cell free PA Vaccines

1.3 Market by Application

1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Human Use

1.3.3 Animal Use

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2017-2028

2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2017-2028

2.3 Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Anthrax Vaccines Sales by Region

2.4.1 Global Anthrax Vaccines Sales by Region (2017-2022)

2.4.2 Global Sales Anthrax Vaccines by Region (2023-2028)

2.5 Global Anthrax Vaccines Revenue by Region

2.5.1 Global Anthrax Vaccines Revenue by Region (2017-2022)

2.5.2 Global Anthrax Vaccines Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Anthrax Vaccines Sales by Manufacturers

3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2017-2022)

3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthrax Vaccines in 2021

3.2 Global Anthrax Vaccines Revenue by Manufacturers

3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2017-2022)

3.2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2021

3.3 Global Anthrax Vaccines Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Anthrax Vaccines Sales by Type

4.1.1 Global Anthrax Vaccines Historical Sales by Type (2017-2022)

4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2023-2028)

4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2017-2028)

4.2 Global Anthrax Vaccines Revenue by Type

4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2017-2022)

4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2023-2028)

4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)

4.3 Global Anthrax Vaccines Price by Type

4.3.1 Global Anthrax Vaccines Price by Type (2017-2022)

4.3.2 Global Anthrax Vaccines Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Anthrax Vaccines Sales by Application

5.1.1 Global Anthrax Vaccines Historical Sales by Application (2017-2022)

5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2023-2028)

5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2017-2028)

5.2 Global Anthrax Vaccines Revenue by Application

5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2017-2022)

5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2023-2028)

5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)

5.3 Global Anthrax Vaccines Price by Application

5.3.1 Global Anthrax Vaccines Price by Application (2017-2022)

5.3.2 Global Anthrax Vaccines Price Forecast by Application (2023-2028)

6 North America

6.1 North America Anthrax Vaccines Market Size by Type

6.1.1 North America Anthrax Vaccines Sales by Type (2017-2028)

6.1.2 North America Anthrax Vaccines Revenue by Type (2017-2028)

6.2 North America Anthrax Vaccines Market Size by Application

6.2.1 North America Anthrax Vaccines Sales by Application (2017-2028)

6.2.2 North America Anthrax Vaccines Revenue by Application (2017-2028)

6.3 North America Anthrax Vaccines Market Size by Country

6.3.1 North America Anthrax Vaccines Sales by Country (2017-2028)

6.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Anthrax Vaccines Market Size by Type

7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2028)

7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2028)

7.2 Europe Anthrax Vaccines Market Size by Application

7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2028)

7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2028)

7.3 Europe Anthrax Vaccines Market Size by Country

7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2028)

7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Anthrax Vaccines Market Size by Type

8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2017-2028)

8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2017-2028)

8.2 Asia Pacific Anthrax Vaccines Market Size by Application

8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2017-2028)

8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2017-2028)

8.3 Asia Pacific Anthrax Vaccines Market Size by Region

8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2017-2028)

8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Anthrax Vaccines Market Size by Type

9.1.1 Latin America Anthrax Vaccines Sales by Type (2017-2028)

9.1.2 Latin America Anthrax Vaccines Revenue by Type (2017-2028)

9.2 Latin America Anthrax Vaccines Market Size by Application

9.2.1 Latin America Anthrax Vaccines Sales by Application (2017-2028)

9.2.2 Latin America Anthrax Vaccines Revenue by Application (2017-2028)

9.3 Latin America Anthrax Vaccines Market Size by Country

9.3.1 Latin America Anthrax Vaccines Sales by Country (2017-2028)

9.3.2 Latin America Anthrax Vaccines Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Anthrax Vaccines Market Size by Type

10.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2017-2028)

10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2028)

10.2 Middle East and Africa Anthrax Vaccines Market Size by Application

10.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2017-2028)

10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2028)

10.3 Middle East and Africa Anthrax Vaccines Market Size by Country

10.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2017-2028)

10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Emergent BioSolutions

11.1.1 Emergent BioSolutions Corporation Information

11.1.2 Emergent BioSolutions Overview

11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Emergent BioSolutions Recent Developments

11.2 Merial

11.2.1 Merial Corporation Information

11.2.2 Merial Overview

11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merial Recent Developments

11.3 Merck

11.3.1 Merck Corporation Information

11.3.2 Merck Overview

11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Merck Recent Developments

11.4 Zoetis

11.4.1 Zoetis Corporation Information

11.4.2 Zoetis Overview

11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Zoetis Recent Developments

11.5 Bayer Sanidad Animal

11.5.1 Bayer Sanidad Animal Corporation Information

11.5.2 Bayer Sanidad Animal Overview

11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Bayer Sanidad Animal Recent Developments

11.6 Colorado Serum

11.6.1 Colorado Serum Corporation Information

11.6.2 Colorado Serum Overview

11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Colorado Serum Recent Developments

11.7 PharmAthene

11.7.1 PharmAthene Corporation Information

11.7.2 PharmAthene Overview

11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 PharmAthene Recent Developments

11.8 Tiankang

11.8.1 Tiankang Corporation Information

11.8.2 Tiankang Overview

11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Tiankang Recent Developments

11.9 Biogénesis-Bago

11.9.1 Biogénesis-Bago Corporation Information

11.9.2 Biogénesis-Bago Overview

11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Biogénesis-Bago Recent Developments

11.10 CAVAC

11.10.1 CAVAC Corporation Information

11.10.2 CAVAC Overview

11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 CAVAC Recent Developments

11.11 Rosenbusch

11.11.1 Rosenbusch Corporation Information

11.11.2 Rosenbusch Overview

11.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Rosenbusch Recent Developments

11.12 Agrovet

11.12.1 Agrovet Corporation Information

11.12.2 Agrovet Overview

11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Agrovet Recent Developments

11.13 Vecol

11.13.1 Vecol Corporation Information

11.13.2 Vecol Overview

11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Vecol Recent Developments

11.14 CVCRI

11.14.1 CVCRI Corporation Information

11.14.2 CVCRI Overview

11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 CVCRI Recent Developments

11.15 IVPM

11.15.1 IVPM Corporation Information

11.15.2 IVPM Overview

11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 IVPM Recent Developments

11.16 Prondil

11.16.1 Prondil Corporation Information

11.16.2 Prondil Overview

11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Prondil Recent Developments

11.17 CDV

11.17.1 CDV Corporation Information

11.17.2 CDV Overview

11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.17.4 CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 CDV Recent Developments

11.18 Indian Immunologicals

11.18.1 Indian Immunologicals Corporation Information

11.18.2 Indian Immunologicals Overview

11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.18.4 Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Indian Immunologicals Recent Developments

11.19 Botswana Vaccine Institute

11.19.1 Botswana Vaccine Institute Corporation Information

11.19.2 Botswana Vaccine Institute Overview

11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Botswana Vaccine Institute Recent Developments

11.20 Ceva Santé Animale

11.20.1 Ceva Santé Animale Corporation Information

11.20.2 Ceva Santé Animale Overview

11.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.20.4 Ceva Santé Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Ceva Santé Animale Recent Developments

11.21 Intervac

11.21.1 Intervac Corporation Information

11.21.2 Intervac Overview

11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.21.4 Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Intervac Recent Developments

11.22 JOVAC

11.22.1 JOVAC Corporation Information

11.22.2 JOVAC Overview

11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.22.4 JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.22.5 JOVAC Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Anthrax Vaccines Industry Chain Analysis

12.2 Anthrax Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Anthrax Vaccines Production Mode & Process

12.4 Anthrax Vaccines Sales and Marketing

12.4.1 Anthrax Vaccines Sales Channels

12.4.2 Anthrax Vaccines Distributors

12.5 Anthrax Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Anthrax Vaccines Industry Trends

13.2 Anthrax Vaccines Market Drivers

13.3 Anthrax Vaccines Market Challenges

13.4 Anthrax Vaccines Market Restraints

14 Key Findings in The Global Anthrax Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Indian Immunologicals

Botswana Vaccine Institute

List of Tables

Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Live Vaccines

Table 3. Major Manufacturers of Cell free PA Vaccines

Table 4. Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)

Table 7. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)

Table 8. Global Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)

Table 9. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)

Table 10. Global Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Anthrax Vaccines Revenue Market Share by Region (2017-2022)

Table 12. Global Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Anthrax Vaccines Revenue Market Share by Region (2023-2028)

Table 14. Global Anthrax Vaccines Sales by Manufacturers (2017-2022) & (M Doses)

Table 15. Global Anthrax Vaccines Sales Share by Manufacturers (2017-2022)

Table 16. Global Anthrax Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Anthrax Vaccines Revenue Share by Manufacturers (2017-2022)

Table 18. Anthrax Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)

Table 19. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2021)

Table 21. Anthrax Vaccines Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Anthrax Vaccines Product Offered

Table 23. Date of Manufacturers Enter into Anthrax Vaccines Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 26. Global Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 27. Global Anthrax Vaccines Sales Share by Type (2017-2022)

Table 28. Global Anthrax Vaccines Sales Share by Type (2023-2028)

Table 29. Global Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Anthrax Vaccines Revenue Share by Type (2017-2022)

Table 32. Global Anthrax Vaccines Revenue Share by Type (2023-2028)

Table 33. Anthrax Vaccines Price by Type (2017-2022) & (USD/Dose)

Table 34. Global Anthrax Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)

Table 35. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 36. Global Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 37. Global Anthrax Vaccines Sales Share by Application (2017-2022)

Table 38. Global Anthrax Vaccines Sales Share by Application (2023-2028)

Table 39. Global Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Anthrax Vaccines Revenue Share by Application (2017-2022)

Table 42. Global Anthrax Vaccines Revenue Share by Application (2023-2028)

Table 43. Anthrax Vaccines Price by Application (2017-2022) & (USD/Dose)

Table 44. Global Anthrax Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)

Table 45. North America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 46. North America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 47. North America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 50. North America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 51. North America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 54. North America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)

Table 55. North America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 58. Europe Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 59. Europe Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 62. Europe Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 63. Europe Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 66. Europe Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)

Table 67. Europe Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 70. Asia Pacific Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 71. Asia Pacific Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 74. Asia Pacific Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 75. Asia Pacific Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)

Table 78. Asia Pacific Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)

Table 79. Asia Pacific Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 82. Latin America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 83. Latin America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 86. Latin America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 87. Latin America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 90. Latin America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)

Table 91. Latin America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)

Table 94. Middle East and Africa Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)

Table 95. Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)

Table 98. Middle East and Africa Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)

Table 99. Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)

Table 102. Middle East and Africa Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)

Table 103. Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 105. Emergent BioSolutions Corporation Information

Table 106. Emergent BioSolutions Description and Major Businesses

Table 107. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 108. Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Emergent BioSolutions Recent Developments

Table 110. Merial Corporation Information

Table 111. Merial Description and Major Businesses

Table 112. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 113. Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Merial Recent Developments

Table 115. Merck Corporation Information

Table 116. Merck Description and Major Businesses

Table 117. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 118. Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Merck Recent Developments

Table 120. Zoetis Corporation Information

Table 121. Zoetis Description and Major Businesses

Table 122. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 123. Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Zoetis Recent Developments

Table 125. Bayer Sanidad Animal Corporation Information

Table 126. Bayer Sanidad Animal Description and Major Businesses

Table 127. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 128. Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Bayer Sanidad Animal Recent Developments

Table 130. Colorado Serum Corporation Information

Table 131. Colorado Serum Description and Major Businesses

Table 132. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 133. Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Colorado Serum Recent Developments

Table 135. PharmAthene Corporation Information

Table 136. PharmAthene Description and Major Businesses

Table 137. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 138. PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. PharmAthene Recent Developments

Table 140. Tiankang Corporation Information

Table 141. Tiankang Description and Major Businesses

Table 142. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 143. Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Tiankang Recent Developments

Table 145. Biogénesis-Bago Corporation Information

Table 146. Biogénesis-Bago Description and Major Businesses

Table 147. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 148. Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Biogénesis-Bago Recent Developments

Table 150. CAVAC Corporation Information

Table 151. CAVAC Description and Major Businesses

Table 152. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 153. CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. CAVAC Recent Developments

Table 155. Rosenbusch Corporation Information

Table 156. Rosenbusch Description and Major Businesses

Table 157. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 158. Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Rosenbusch Recent Developments

Table 160. Agrovet Corporation Information

Table 161. Agrovet Description and Major Businesses

Table 162. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 163. Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Agrovet Recent Developments

Table 165. Vecol Corporation Information

Table 166. Vecol Description and Major Businesses

Table 167. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 168. Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Vecol Recent Developments

Table 170. CVCRI Corporation Information

Table 171. CVCRI Description and Major Businesses

Table 172. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 173. CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. CVCRI Recent Developments

Table 175. IVPM Corporation Information

Table 176. IVPM Description and Major Businesses

Table 177. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 178. IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 179. IVPM Recent Developments

Table 180. Prondil Corporation Information

Table 181. Prondil Description and Major Businesses

Table 182. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 183. Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 184. Prondil Recent Developments

Table 185. CDV Corporation Information

Table 186. CDV Description and Major Businesses

Table 187. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 188. CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 189. CDV Recent Developments

Table 190. Indian Immunologicals Corporation Information

Table 191. Indian Immunologicals Description and Major Businesses

Table 192. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 193. Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 194. Indian Immunologicals Recent Developments

Table 195. Botswana Vaccine Institute Corporation Information

Table 196. Botswana Vaccine Institute Description and Major Businesses

Table 197. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 198. Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 199. Botswana Vaccine Institute Recent Developments

Table 200. Ceva Santé Animale Corporation Information

Table 201. Ceva Santé Animale Description and Major Businesses

Table 202. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 203. Ceva Santé Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 204. Ceva Santé Animale Recent Developments

Table 205. Intervac Corporation Information

Table 206. Intervac Description and Major Businesses

Table 207. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 208. Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 209. Intervac Recent Developments

Table 210. JOVAC Corporation Information

Table 211. JOVAC Description and Major Businesses

Table 212. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 213. JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 214. JOVAC Recent Developments

Table 215. Key Raw Materials Lists

Table 216. Raw Materials Key Suppliers Lists

Table 217. Anthrax Vaccines Distributors List

Table 218. Anthrax Vaccines Customers List

Table 219. Anthrax Vaccines Market Trends

Table 220. Anthrax Vaccines Market Drivers

Table 221. Anthrax Vaccines Market Challenges

Table 222. Anthrax Vaccines Market Restraints

Table 223. Research Programs/Design for This Report

Table 224. Key Data Information from Secondary Sources

Table 225. Key Data Information from Primary Sources

List of Figures

Figure 1. Anthrax Vaccines Product Picture

Figure 3. Global Anthrax Vaccines Market Share by Type in 2021 & 2028

Figure 3. Live Vaccines Product Picture

Figure 4. Cell free PA Vaccines Product Picture

Figure 5. Global Anthrax Vaccines Market Share by Application in 2021 & 2028

Figure 6. Human Use

Figure 7. Animal Use

Figure 8. Anthrax Vaccines Report Years Considered

Figure 9. Global Anthrax Vaccines Sales 2017-2028 (M Doses)

Figure 10. Global Anthrax Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Anthrax Vaccines Revenue 2017-2028 (US$ Million)

Figure 12. Global Anthrax Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 13. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)

Figure 14. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)

Figure 15. North America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)

Figure 16. North America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 17. Europe Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)

Figure 18. Europe Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Asia-Pacific Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)

Figure 20. Asia-Pacific Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Latin America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)

Figure 22. Latin America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Middle East & Africa Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)

Figure 24. Middle East & Africa Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 25. The Anthrax Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 26. The Top 5 and 10 Largest Manufacturers of Anthrax Vaccines in the World: Market Share by Anthrax Vaccines Revenue in 2021

Figure 27. Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 28. Global Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 29. Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 30. Global Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 31. Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 32. North America Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 33. North America Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 34. North America Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 35. North America Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 36. North America Anthrax Vaccines Sales Share by Country (2017-2028)

Figure 37. North America Anthrax Vaccines Revenue Share by Country (2017-2028)

Figure 38. U.S. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 39. Canada Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 40. Europe Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 41. Europe Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 42. Europe Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 43. Europe Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 44. Europe Anthrax Vaccines Sales Share by Country (2017-2028)

Figure 45. Europe Anthrax Vaccines Revenue Share by Country (2017-2028)

Figure 46. Germany Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 47. France Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 48. U.K. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 49. Italy Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 50. Russia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 51. Asia Pacific Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 52. Asia Pacific Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 53. Asia Pacific Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 54. Asia Pacific Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 55. Asia Pacific Anthrax Vaccines Sales Share by Region (2017-2028)

Figure 56. Asia Pacific Anthrax Vaccines Revenue Share by Region (2017-2028)

Figure 57. China Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 58. Japan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 59. South Korea Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 60. India Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 61. Australia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 62. China Taiwan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 63. Indonesia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 64. Thailand Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 65. Malaysia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 66. Latin America Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 67. Latin America Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 68. Latin America Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 69. Latin America Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 70. Latin America Anthrax Vaccines Sales Share by Country (2017-2028)

Figure 71. Latin America Anthrax Vaccines Revenue Share by Country (2017-2028)

Figure 72. Mexico Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 73. Brazil Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 74. Argentina Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 75. Middle East and Africa Anthrax Vaccines Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Anthrax Vaccines Revenue Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Anthrax Vaccines Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Anthrax Vaccines Revenue Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Anthrax Vaccines Sales Share by Country (2017-2028)

Figure 80. Middle East and Africa Anthrax Vaccines Revenue Share by Country (2017-2028)

Figure 81. Turkey Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 82. Saudi Arabia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 83. UAE Anthrax Vaccines Revenue (2017-2028) & (US$ Million)

Figure 84. Anthrax Vaccines Value Chain

Figure 85. Anthrax Vaccines Production Process

Figure 86. Channels of Distribution

Figure 87. Distributors Profiles

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

Global Anthrax Vaccines Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-8216

Global Anthrax Vaccines Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions